Andrew Guggenhime insider trades

Open-market stock purchases and sales by Andrew Guggenhime, PRESIDENT AND CFO at Vaxcyte, Inc, from SEC Form 4 filings since Apr 3, 2010.

Recent trades

DateStockTradeValue
Sep 8, 2026PCVX Vaxcyte, IncSold (not open market)$432K
Sep 2, 2026PCVX Vaxcyte, IncSold (not open market)$88.2K
Aug 31, 2026PCVX Vaxcyte, IncSold (not open market)$77.3K
Aug 3, 2026PCVX Vaxcyte, IncSold$374K
Aug 3, 2026PCVX Vaxcyte, IncSold$165K
Aug 3, 2026PCVX Vaxcyte, IncBought (not open market)—
Jul 6, 2026PCVX Vaxcyte, IncSold$452K
Jul 6, 2026PCVX Vaxcyte, IncSold$121K
Jul 6, 2026PCVX Vaxcyte, IncBought (not open market)—
Jun 18, 2026PCVX Vaxcyte, IncSold$530K
Jun 18, 2026PCVX Vaxcyte, IncBought (not open market)—
Mar 9, 2026PCVX Vaxcyte, IncSold (not open market)$60.6K
Mar 2, 2026PCVX Vaxcyte, IncSold (not open market)$62.5K
Feb 28, 2026PCVX Vaxcyte, IncSold (not open market)$55.7K
Feb 26, 2026PCVX Vaxcyte, IncBought (not open market)—
Feb 26, 2026PCVX Vaxcyte, IncBought (not open market)—
Feb 20, 2026CRBU Caribou Biosciences, IncBought (not open market)—
Jan 14, 2026PCVX Vaxcyte, IncBought (not open market)—

Companies traded

  • PCVX Vaxcyte, Inc: 68 sales, last Sep 8, 2026
  • CRBU Caribou Biosciences, Inc: other filings, last Feb 20, 2026
  • MTCR Metacrine, Inc: other filings, last May 18, 2022
  • DERM Dermira, Inc: 8 sales, last Feb 20, 2020
  • FACT Facet Biotech Corp: other filings, last Apr 21, 2010

Get free alerts when Andrew Guggenhime files a new trade →